Abstract:Background: Standard Modifiable Cardiovascular Risk Factors (SMuRF) such as hypertension, diabetes mellitus, hyperlipidemia, and smoking have long been established in the etiology of atherosclerotic disease. We evaluate in-hospital outcomes of female STEMI patients without these risk factors. Methods: The National Inpatient Sample databases (2016 to 2021) were queried to identify STEMI admissions as a principal diagnosis using ICD 10 codes. Patients with a history of coronary artery disease, myocardial infarction, coronary bypass graft, percutaneous coronary intervention, takotsubo cardiomyopathy, cocaine abuse, and spontaneous coronary dissection and males were excluded from our study population. A final study population aged >18 years was divided into cohorts of SMuRF and SMuRF-less based on the presence of ≥1 risk factor. Multivariate logistic regression model adjusting for baseline characteristics and comorbidities. The primary outcome was in-hospital mortality. The secondary outcomes are STEMI-related complications, and the use of mechanical circulatory support devices. Results: 200,980 patients were identified. 187,776 (93.4%) patients were identified as having ≥1 SMuRF, and 13,205 (6.6%) patients were SMuRF-less. Compared to SMuRF patients, SMuRF-less patients are more likely to be white (75.6% vs. 73.1%, p<0.01) and older median age (69 years [IQR: 58-78] vs 67 years [IQR: 57-81], p<0.01). In comparing co-morbidities, SMuRF-less patients were less likely to have heart failure (28.0% vs. 23.4%, p<0.01), atrial fibrillation/flutter (16.1% vs. 14.6%, p=0.03), chronic pulmonary disease (18.9% vs. 9.5%, p<0.01), obesity (20.7% vs. 9.2%, p<0.01) and aortic disease (1.1% vs. 0.6%, p<0.01). They were however more likely to have dementia (6.9% vs. 5.7%, p<0.01). In evaluating outcomes, SMuRF-less patients had higher in-hospital mortality (aOR 3.2 [95% CI, 2.9 - 3.6]; P<0.01), acute heart failure (aOR 1.6 [95% CI, 1.4 - 1.8]; P<0.01), acute kidney injury (aOR 1.8 [95% CI, 1.7 - 2.1]; P<0.01), and Intra-aortic balloon pump (aOR 1.7 [95% CI, 1.5 - 1.9]; P<0.01). Predictors of higher mortality in SMuRF-less patients include chronic liver disease (OR 6.8, CI 2.4-19.4, p<0.01), and Hispanic race (OR 1.62, CI 1.1-2.5, p<0.01). We also found that SMuRF-less patients were less likely to undergo coronary angiography (aOR 0.5 [95% CI, 0.4 - 0.5]; P<0.01) and percutaneous coronary intervention (aOR 0.7 [95% CI, 0.6 - 0.8]; P<0.01). Conclusion: Female SMuRF-less patients presenting with STEMI have worse in-hospital outcomes when compared to patients with ≥1SMuRF.

Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors

Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors-A DANAMI-3 substudy

Role of ST‐Segment Resolution Alone and in Combination with TIMI Flow after Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction

Clinical outcomes and coronary artery lesion characteristics of young patients with ST elevation myocardial infarction and no standard modifiable risk factors

Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors

Mortality of Patients Presented with Acute ST-Segment Elevation Myocardial Infarction According to the Status of Standard Modifiable Cardiovascular Risk Factors

Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention

Characteristics and In-hospital Outcomes of Female Patients Presenting with ST-Segment-Elevation Myocardial Infarction Without Standard Modifiable Cardiovascular Risk Factors

Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors

Impact of Standard Modifiable Cardiovascular Risk Factors on 2-Year All-Cause Mortality: Insights from an International Cohort of 23,489 Patients with Acute Coronary Syndrome

In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

Acute Response in the Noninfarcted Myocardium Predicts Long-Term Major Adverse Cardiac Events After STEMI

Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction

Coronary Artery Disease Without Standard Cardiovascular Risk Factors

Pattern of Standard Modifiable Risk Factors and Outcomes in Very Young Patients with Myocardial Infarction

Clinical and Vessel Characteristics Associated with Hard Outcomes after PCI and Their Combined Prognostic Implications.

Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies

Clinical characteristics and outcomes of patients with acute coronary syndrome without standard metabolic cardiovascular risk factors

Predictors of Suboptimal Coronary Blood Flow after Primary Angioplasty and Its Implications on Short-Term Outcomes in Patients with Acute Anterior STEMI.

10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population